HER2 as a potential therapeutic target on quiescent prostate cancer cells

Quiescent prostate cancer (PCa) cells are common in tumors but are often resistant to chemotherapy. Quiescent PCa cells are also enriched for a stem-like tumor initiating population, and can lead to recurrence after dormancy. Unfortunately, quiescent PCa cells are difficult to identify and / or targ...

Descripción completa

Detalles Bibliográficos
Autores principales: Yumoto, Kenji, Rashid, Jibraan, Ibrahim, Kristina G., Zielske, Steven P., Wang, Yu, Omi, Maiko, Decker, Ann M., Jung, Younghun, Sun, Dan, Remmer, Henriette A., Mishina, Yuji, Buttitta, Laura A., Taichman, Russell S., Cackowski, Frank C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9971552/
https://www.ncbi.nlm.nih.gov/pubmed/36805918
http://dx.doi.org/10.1016/j.tranon.2023.101642

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9971552/
https://www.ncbi.nlm.nih.gov/pubmed/36805918
http://dx.doi.org/10.1016/j.tranon.2023.101642

Ejemplares similares